Pinkerton Retirement Specialists’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-152
Closed -$18K 628
2016
Q4
$18K Buy
152
+11
+8% +$1.23K 0.01% 329
2016
Q3
$15K Buy
141
+3
+2% +$325 0.01% 356
2016
Q2
$14K Buy
138
+65
+89% +$6.72K 0.01% 355
2016
Q1
$4K Buy
73
+21
+40% +$2.16K ﹤0.01% 147
2015
Q4
$6K Hold
52
﹤0.01% 108
2015
Q3
$6K Hold
52
0.01% 110
2015
Q2
$6K Buy
+52
New +$5.95K ﹤0.01% 119

Other funds holding CELG

Pinkerton Retirement Specialists's CELG Position: Q1 2017 in Review

Pinkerton Retirement Specialists sold out of Celgene Corp (CELG) in Q1 2017, closing a stake of 152 shares — an estimated $18K sold.

Pinkerton Retirement Specialists first reported a position in CELG in Q2 2015 and held it in 7 quarters. The position peaked at $18K in Q4 2016. 1,417 funds tracked by Wall St. Rank hold CELG as of Q1 2017.

  • Pinkerton Retirement Specialists reported no remaining Celgene Corp position as of Q1 2017 after selling out during the quarter.
  • Pinkerton Retirement Specialists sold 152 Celgene Corp shares in Q1 2017, an estimated $18K.
  • Pinkerton Retirement Specialists first reported a position in Celgene Corp in Q2 2015 and held it in 7 quarters.
  • Pinkerton Retirement Specialists's Celgene Corp position peaked at $18K in Q4 2016.
  • 1,417 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2017.

Based on Pinkerton Retirement Specialists's 13F filing for Q1 2017, filed 15 May 2017.